Literature DB >> 27754470

Prostate cancer: Estimated life expectancy: integration of age and comorbidities.

Axel Heidenreich1, David Pfister1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27754470     DOI: 10.1038/nrurol.2016.203

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Patient comorbidity is associated with conservative treatment of localized prostate cancer.

Authors:  Christina G Jespersen; Mette Nørgaard; Jacob B Jacobsen; Michael Borre
Journal:  Scand J Urol       Date:  2015-04-22       Impact factor: 1.612

2.  Comorbidity and competing risks for mortality in men with prostate cancer.

Authors:  Timothy J Daskivich; Karim Chamie; Lorna Kwan; Jessica Labo; Atreya Dash; Sheldon Greenfield; Mark S Litwin
Journal:  Cancer       Date:  2011-04-08       Impact factor: 6.860

3.  Limitations of the National Comprehensive Cancer Network® (NCCN®) Guidelines for Prediction of Limited Life Expectancy in Men with Prostate Cancer.

Authors:  Timothy J Daskivich; Lauren N Wood; Douglas Skarecky; Thomas Ahlering; Stephen Freedland
Journal:  J Urol       Date:  2016-08-28       Impact factor: 7.450

Review 4.  Clinical practice guidelines on prostate cancer: a critical appraisal.

Authors:  Mohit Gupta; John McCauley; Amy Farkas; Ahmet Gudeloglu; Molly M Neuberger; Yen-Yi Ho; Lawrence Yeung; Johannes Vieweg; Philipp Dahm
Journal:  J Urol       Date:  2014-11-04       Impact factor: 7.450

Review 5.  Early detection of prostate cancer: European Association of Urology recommendation.

Authors:  Axel Heidenreich; Per-Anders Abrahamsson; Walter Artibani; James Catto; Francesco Montorsi; Hein Van Poppel; Manfred Wirth; Nicolas Mottet
Journal:  Eur Urol       Date:  2013-07-09       Impact factor: 20.096

6.  Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk.

Authors:  Pierre Lunardi; Guillaume Ploussard; Pascale Grosclaude; Mathieu Roumiguié; Michel Soulié; Jean Baptiste Beauval; Bernard Malavaud
Journal:  World J Urol       Date:  2016-07-21       Impact factor: 4.226

7.  Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.

Authors:  Jochen Walz; Andrea Gallina; Paul Perrotte; Claudio Jeldres; Quoc-Dien Trinh; Georg C Hutterer; Miriam Traumann; Alvaro Ramirez; Shahrokh F Shariat; Michael McCormack; Jean-Paul Perreault; Francois Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2007-12       Impact factor: 5.588

8.  Questioning the 10-year Life Expectancy Rule for High-grade Prostate Cancer: Comparative Effectiveness of Aggressive vs Nonaggressive Treatment of High-grade Disease in Older Men With Differing Comorbid Disease Burdens.

Authors:  Timothy J Daskivich; Julie Lai; Andrew W Dick; Claude M Setodji; Janet M Hanley; Mark S Litwin; Christopher Saigal
Journal:  Urology       Date:  2016-04-11       Impact factor: 2.649

9.  A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.

Authors:  Michael Froehner; Anna-Elisa Kellner; Rainer Koch; Gustavo B Baretton; Oliver W Hakenberg; Manfred P Wirth
Journal:  BMC Urol       Date:  2014-03-29       Impact factor: 2.264

10.  Effect of major lifestyle risk factors, independent and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES).

Authors:  Mark G O'Doherty; Karen Cairns; Vikki O'Neill; Felicity Lamrock; Torben Jørgensen; Hermann Brenner; Ben Schöttker; Tom Wilsgaard; Galatios Siganos; Kari Kuulasmaa; Paolo Boffetta; Antonia Trichopoulou; Frank Kee
Journal:  Eur J Epidemiol       Date:  2016-01-18       Impact factor: 8.082

  10 in total
  1 in total

Review 1.  [Limits of surgery in uro-oncology].

Authors:  A Heidenreich
Journal:  Urologe A       Date:  2018-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.